DOPRAM Drug Patent Profile
✉ Email this page to a colleague
When do Dopram patents expire, and when can generic versions of Dopram launch?
Dopram is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in DOPRAM is doxapram hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the doxapram hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dopram
A generic version of DOPRAM was approved as doxapram hydrochloride by CHARTWELL INJECTABLE on January 10th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOPRAM?
- What are the global sales for DOPRAM?
- What is Average Wholesale Price for DOPRAM?
Summary for DOPRAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 230 |
| Clinical Trials: | 3 |
| Patent Applications: | 1,148 |
| Drug Prices: | Drug price information for DOPRAM |
| What excipients (inactive ingredients) are in DOPRAM? | DOPRAM excipients list |
| DailyMed Link: | DOPRAM at DailyMed |
Recent Clinical Trials for DOPRAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 3 |
| Universitaire Ziekenhuizen Leuven | Phase 3 |
| Nederlands Neonataal Netwerk (N3), the Netherlands | Phase 3 |
Pharmacology for DOPRAM
| Drug Class | Respiratory Stimulant |
| Physiological Effect | Increased Medullary Respiratory Drive |
US Patents and Regulatory Information for DOPRAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | DOPRAM | doxapram hydrochloride | INJECTABLE;INJECTION | 014879-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
